Search

Author/Creator Patel, Parul

1. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies. (31st December 2020)

Authors:
Teichner, Paula; Wu, Sterling; Zhang, Feifan; Dorey, David; D'Amico, Ronald; Griffith, Sandy; Sutton, Kenneth; McCoig, Cynthia C; Upadhyay, Ojesh R; Polli, Joseph; Margolis, David; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William; Patel, Parul
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S544
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1586. Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy and Safety Outcomes Through Week 96 by Race. (15th December 2022)

Authors:
Patel, Parul; Elliot, Emilie; D'Amico, Ronald; Garside, Louise; Smith, Conor; Roberts, Jeremy; Polli, Joseph W; Ramgopal, Moti; Kumar, Princy N; Osiyemi, Olayemi; Baugh, Bryan; van Wyk, Jean A
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 552. Evaluation of Relationships Between UGT1A1 Genotypes and Cabotegravir Long-Acting Injection Pharmacokinetics Among HIV-Infected Subjects in the LATTE-2 Study. (26th November 2018)

Authors:
Xue, Zhengyu; King, Karen S; Ford, Susan L; Lou, Yu; Bakshi, Kalpana K; Margolis, David A; Hughes, Arlene R; Spreen, William R; Patel, Parul
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S205
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 637Control of Methicillin-Resistant Staphylococcus aureus (MRSA) in Long Term Care is Possible While Maintaining Patient Socialization without Isolation. (December 2014)

Authors:
Smith, Becky; Boehm, Susan; Beaumont, Jennifer; Robicsek, Ari; Patel, Parul; Schora, Donna; Burdsall, Deborah; Peterson, Kari; Fausone, Maureen; Peterson, Lance
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 866Observational Study of Central Venous Catheter (CVC) Occlusions and Central Line-Associated Blood Stream Infections (CLABSI) Using the Clave™ Negative Displacement Connector. (December 2014)

Authors:
Patel, Parul; Boehm, Susan; Zhou, Ying; Zhu, Catherine; Peterson, Kari; Grayes, Althea; Peterson, Lance
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes. (4th December 2021)

Authors:
Taiwo, Babafemi O; Tan, Darrell; Patel, Parul; Teichner, Paula; Polli, Joseph; Garside, Louise; D'Amico, Ronald; Talarico, Christine L; Van Solingen-Ristea, Rodica; Baugh, Bryan; Spreen, William; Aboud, Michael; Bosse, Matthew
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S530
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials. (4th December 2021)

Authors:
Patel, Parul; Ford, Susan L; Baker, Mark; Meyer, Claudia; Garside, Louise; D'Amico, Ronald; Van Solingen-Ristea, Rodica; Crauwels, Herta; Polli, Joseph; Seal, Ciara; Thiagarajah, Shanker; Birmingham, Eileen; Spreen, William; Baugh, Bryan; Bosse, Matthew; Vannappagari, Vani
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Issue 9 (20th March 2023)

Authors:
Gounder, Mrinal M.; Bauer, Todd M.; Schwartz, Gary K.; Weise, Amy M.; LoRusso, Patricia; Kumar, Prasanna; Tao, Ben; Hong, Ying; Patel, Parul; Lu, Yasong; Lesegretain, Arnaud; Tirunagaru, Vijaya G.; Xu, Feng; Doebele, Robert C.; Hong, David S.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 9(2023)
Page Start:
1714
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls. Issue 5 (27th February 2019)

Authors:
Shaik, Jafar Sadik B.; Ford, Susan L.; Lou, Yu; Zhang, Zhiping; Bakshi, Kalpana K.; Tenorio, Allan R.; Trezza, Christine; Spreen, William R.; Patel, Parul
Journal:
Clinical pharmacology in drug development
Issue:
Volume 8:Issue 5(2019)
Page Start:
664
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants. Issue 5 (27th February 2019)

Authors:
Parasrampuria, Ridhi; Ford, Susan L.; Lou, Yu; Fu, Caifeng; Bakshi, Kalpana K.; Tenorio, Allan R.; Trezza, Christine; Spreen, William R.; Patel, Parul
Journal:
Clinical pharmacology in drug development
Issue:
Volume 8:Issue 5(2019)
Page Start:
674
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗